experimental drugs

Wikimedia Commons

The House rejected legislation Tuesday easing how experimental drugs are provided to people with terminal illnesses, as Democrats calling the bill risky and misleading overcame support from President Donald Trump and emotional arguments by Republican lawmakers and ailing constituents.

Wikimedia Commons

A leading House Democrat announced his opposition Monday to a Republican bill making it easier for some terminally ill patients to try experimental drugs, clouding the measure's fate.

Wikimedia Commons

The Food and Drug Administration removed an obstacle from of its “compassionate use” policy this month, eliminating some paperwork that physicians must do to obtain experimental drugs for some patients with immediately life-threatening illnesses.

RighttoTry.org

While the “Right to Try Act,” which aims to give dying patients the right to try unapproved experimental drugs, is law in Florida as of today, its implementation isn't so clear.

In theory, the Right to Try law allows terminally ill patients access to drugs that have passed first-phase clinical trials and are going through later-stage trials as part of a new drug application to the Food and Drug Administration.

Experimental Drug Bill Awaits Scott Action

Jun 1, 2015
University of Washington Health

The Florida House this week sent a bill (HB 269) to Gov. Rick Scott that would allow terminally ill patients to have access to experimental drugs.

The bill, filed by Rep. Ray Pilon, R-Sarasota, drew significant discussion during this year's regular legislative session, with Pilon and other supporters saying it could help people with diseases such as cancer.

The bill focuses on drugs that have been through what is known as "phase 1" of a clinical trial but have not been approved for general use by the U.S. Food and Drug Administration.

The Florida House has passed a bill that creates the “Right to Try Act.”  The legislation gives dying patients a chance to try treatments that have undergone clinical trials but haven’t been approved by the Food and Drug Administration.  

Patients who’ve been diagnosed as having less than a year to live would be eligible for the experimental treatments.